Investment led by Foresite Capital with strategic investment by Microsoft will support expansion in translational informatics, clinical trials, and broadened use of biomedical data MOUNTAIN VIEW, Calif.–DNAnexus, Inc., the global leader in biomedical informatics and data management, today announced closing a $58 million financing led by new investor Foresite Capital with strategic investment from Microsoft […]
Helsinki – MediSapiens, a leading developer and provider of genomic, biomedical and healthcare data solutions, joins the recently announced 59M€ FinnGen project, that aims at improving human health through genetically profiling 500.000 Finns, and combining that with a rich set of clinical data to identify new therapeutic targets, as well as diagnostic and prognostic markers […]
CAMBRIDGE, Mass. and PHILADELPHIA, PA — Ovation.io, Inc. (Ovation), makers of the fastest-growing clinical laboratory information and commercialization platform, and Coriell Life Sciences, Inc., an innovative provider of clinical genetic reporting solutions, announced today a partnership and platform integration designed to create a seamless ecosystem for sample and workflow management, genetic data interpretation, and external client […]
Bright Angel Therapeutics to leverage Schrödinger’s best-in-class drug discovery platforms to develop novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections New York, NY and Toronto, Canada – Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and MaRS Innovation, a non-profit organization supporting the commercialization of research breakthroughs […]
Innovative enterprise platform for clinical cross-omics now also accessible via high-performance cloud computing services Microsoft Azure and Amazon Web Services Basel, Switzerland Genedata, a leading provider of advanced software solutions for biopharmaceutical research and development (R&D), today announced that Genedata ProfilerTM, its leading enterprise software platform for omics-based profiling of patients in translational and clinical […]
Palo Alto, California — PREMIER Biosoft today announced the release of SimGlycan 5.90. The new version is about five times faster than the last version and allows for more accurate glycan identification with the updated algorithms. Additionally, SimGlycan now offers an intuitive data analysis automation interface. The key features included are: More Efficient LC-MS Peak Picking Algorithm: Accurate […]
RIJSWIJK, NETHERLANDS and IRVINE, CA, AMSTERDAM, – Bluebee, a company driving global genomic data-driven medicine, and Agendia, Inc, a world leader in personalized medicine and molecular cancer diagnostics, have partnered to provide a secure, convenient, data processing solution for Agendia’s MammaPrint BluePrint Breast Cancer Recurrence and Molecular Subtyping Kit, which is intended for prognostic use […]
Schrödinger to Receive Research Funding and Milestone Payments from ONO New York, NY － Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration with Ono Pharmaceutical (ONO) to develop novel therapeutics. Under the terms of the agreement, the companies will work together to leverage Schrödinger’s computational […]
BC Platforms, a world leader in genomic data management and analysis solutions, announces co-operation with FinnGen program. FinnGen is a unique study that has been launched in Finland. Program will deepen our understanding about the origins of diseases and their treatment. The FinnGen study plans to tap into 500 000 unique blood samples collected by […]
Community-owned database empowers individuals with cryptocurrency for contributing genomic data SAN DIEGO — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included several individual investors and former executives from Illumina ILMN 0.34%, the world leader in DNA sequencing and […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
